# Eliglustat Tartrate (Cerdelga)

Source: https://ourhealthnetwork.com/drugs/eliglustat-tartrate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Eliglustat Tartrate?

Eliglustat Tartrate (brand name: Cerdelga) is a glucosylceramide synthase inhibitor. It is prescribed to treat gaucher disease. Across the United States, 51 doctors prescribe Eliglustat to approximately 15 Medicare patients.

## Brand names

Cerdelga

## Indications

Eliglustat Tartrate is primarily prescribed for the treatment of gaucher disease.

## Conditions treated

- [Gaucher Disease](https://ourhealthnetwork.com/conditions/gaucher-disease)

## Mechanism of action

Gaucher disease is caused by a deficiency of the lysosomal enzyme acid β-glucosidase. Acid β-glucosidase catalyzes the conversion of the sphingolipid glucocerebroside into glucose and ceramide.

## Drug classification

- Established Pharmacologic Class: Glucosylceramide Synthase Inhibitor [EPC]
- Mechanism of Action class: Glucosylceramide Synthase Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

back pain, diarrhea, fatigue, headache, nausea, pain in extremities, upper abdominal pain

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)